Results 101 to 110 of about 3,156 (181)

[Dystrophic epidermolysis bullosa].

Actas dermo-sifiliograficas, 1998
, GOMEZ ORBANEJA, , LEDO POZUETA
openaire   +1 more source

Real-world Experience with JAK Inhibitors and Dupilumab in Dystrophic Epidermolysis Bullosa: A Case Report and Literature Review. [PDF]

Acta Derm Venereol
Ling S, Dou X.
europepmc   +1 more source

Interdisciplinary Approach in Pediatric Patients With Recessive Dystrophic Epidermolysis Bullosa: Experience From the Dermatology Service and the Palliative Care and Complex Chronic Patient Team at Sant Joan de Déu Hospital (Barcelona, Spain). [PDF]

J Eval Clin Pract
Martínez-Ripoll JM, García-Domingo M, De la Fuente Robles YM.   +2 more
europepmc   +1 more source

SOX2 Is a Potential Diagnostic Biomarker and Anticancer Target in Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa: A Case Series Study. [PDF]

JID Innov
Harrs C, Bolling M, van den Akker P, Koopman B, Horváth B, Diercks G, van Kempen L.   +6 more
europepmc   +1 more source

Gynaeco-obstetrical follow-up of patients with dystrophic epidermolysis bullosa, a prospective study. [PDF]

Orphanet J Rare Dis
Fournier M, Bourrat E, Rapp J, Vexiau D, Trastour C, Chiaverini C.   +5 more
europepmc   +1 more source

Results of a non-randomized, open-label phase I study evaluating the novel immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa. [PDF]

Orphanet J Rare Dis
Wallblom K, Holmgren K, Lundgren S, Belfrage E, Hoppe T, Hugerth M, Lindqvist AK, Sonkoly E, Schmidtchen A.   +8 more
europepmc   +1 more source

Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa. [PDF]

Br J Dermatol
Pathmarajah P, Eid E, Nazaroff J, So J, Mittal V, Harris N, Li S, Lucky AW, Gorell ES, Peoples KG, Pope E, Lara-Corrales I, Paller AS, Wiss K, Perman MJ, Eichenfield LF, Levy ML, Morel KD, García-Romero MT, McCuaig CC, Saber M, Marinkovich MP, Oro A, Bruckner AL, Tang JY.   +24 more
europepmc   +1 more source

Human urine-derived stem cells rescue cutaneous manifestation and suppress inflammation and fibrosis <i>in vitro</i> and in a mouse model of recessive dystrophic epidermolysis bullosa. [PDF]

Burns Trauma
Zhou X, Tan J, Song Y, Liu P, Zhang X, Feng X, Xiao Y, Wang Y, Liu G, Zhang W, Zhang Q, Jiang Y, Liu Y, Zhao L, Xie H, Li W.   +15 more
europepmc   +1 more source

Inflammatory modulation by cord blood stem cells prevented digit deformation in recessive dystrophic epidermolysis bullosa. [PDF]

Mol Ther
Anderson-Crannage M, Nyström A, Hirani R, Schaefer E, Hochberg B, Kann R, Pan J, Tian M, Zhu H, Luo W, Ayello J, Cairo MS, Liao Y.   +12 more
europepmc   +1 more source

Natural history study of recessive dystrophic epidermolysis bullosa wounds and patient reported outcomes using mobile application home photography. [PDF]

Sci Rep
Fulchand S, Nazaroff J, Harris N, So JY, Villanueva Gaona R, Alvarez E, Li S, Lu Y, Eid E, Tang JY.   +9 more
europepmc   +1 more source